New guidelines for corticosteroid-induced osteoporosis
نویسندگان
چکیده
منابع مشابه
New osteoporosis guidelines for Canada.
CMAJ • NOVEMBER 23, 2010 • 182(17) © 2010 Canadian Medical Association or its licensors 1829 A lthough osteoporosis has been documented for many years, the disease and the fractures that arise were commonly viewed as inevitable consequences of the aging process. The publication by the World Health Organization (WHO) of a report on the assessment of fracture risk and its application to screening...
متن کاملFluoride treatment in corticosteroid induced osteoporosis.
Severe osteoporosis with multiple vertebral fractures occurred in two girls receiving prolonged high dose corticosteroids for relapsing dermatomyositis. Sodium fluoride, supplemented with calcium and vitamin D, helped control secondary osteoporosis in one case and should be considered as part of the curative treatment of corticoid induced osteoporosis.
متن کاملPrevention and Treatment of Corticosteroid-Induced Osteoporosis
Osteoporosis is one of the most serious complications of corticosteroid treatment. Loss of bone mineral density (BMD) and fractures occur early in the course of corticosteroid treatment, and thus early recognition of fracture risk and effective intervention based on evidence-based-medicine (EBM) are needed. A study of meta-analysis representing the highest level in a hierarchy of evidence showe...
متن کاملIntermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.
BACKGROUND AND METHODS Osteoporosis is a recognized complication of corticosteroid therapy. Whether it can be prevented is not known. We conducted a 12-month, randomized, placebo-controlled study of intermittent etidronate (400 mg per day for 14 days) followed by calcium (500 mg per day for 76 days), given for four cycles, in 141 men and women (age, 19 to 87 years) who had recently begun high-d...
متن کاملGuidelines for the prevention and treatment of glucocorticoid-induced osteoporosis.
UNLABELLED Glucocorticoids (GC) are used in almost all medical specialties, and approximately 0.5% of the general population of the United Kingdom receives those medications. With the increased survival of patients with rheumatological diseases, morbidity secondary to the use of those medications represents an important aspect of the management of our patients. The incidences of vertebral and n...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rheumatology
سال: 2004
ISSN: 1460-2172
DOI: 10.1093/rheumatology/keh095